This article explores how challenges such as sequence optimization, immune activation and off-target effects are being addressed to enhance the safety, durability and efficacy of RNA therapeutics.
Researchers have developed a groundbreaking microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called ...
CEATEC 2025 featured the usual lineup of AI demos, service robots, and experimental interfaces. But inside Hall 4, a quieter, lab-style booth ...
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes ...
BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...
Researchers in Beijing have generated a transcriptomic atlas comparing human fetal tooth germs from the upper and lower jaws at the critical cap stage of development. Previous studies of tooth ...
Researchers at Stockholm University have extracted and sequenced the oldest known RNA molecules in the world (Cell 2025, DOI: 10.1016/j.cell.2025.10.025). The ancient RNA (aRNA) comes from skin and ...
RNA modifications are increasingly recognized as clinically relevant biomarkers, revealing immune dysregulation in autoimmune disease, early oncogenic signaling, and RNA misprocessing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback